APO Research
Talk to an analyst

APO RESEARCH · REPORT

E-Prescribing (eRx) Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global E-Prescribing (eRx) Platform Market Outlook and Growth Opportunities 2026

12 August 2026207 pages

Choose your research edition.

Industry ResearchE-Prescribing (eRx) Platform Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal E-Prescribing (eRx) Platform Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal E-Prescribing (eRx) Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E-Prescribing (eRx) Platform Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal E-Prescribing (eRx) Platform Market Analysis and Forecast 2026-2032188 pages · $4,950 USD

Market perspective

The global E-Prescribing (eRx) Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for E-Prescribing (eRx) Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for E-Prescribing (eRx) Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for E-Prescribing (eRx) Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the E-Prescribing (eRx) Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the E-Prescribing (eRx) Platform market include MediRecords, RxSure, DrFirst, DoseSpot, Veradigm (Allscripts), Practice Fusion, Chetu, Ensora (formerly NewCrop) and Qualifacts, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global E-Prescribing (eRx) Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of E-Prescribing (eRx) Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents E-Prescribing (eRx) Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global E-Prescribing (eRx) Platform market.

E-Prescribing (eRx) Platform Segment by Company

MediRecords

RxSure

DrFirst

DoseSpot

Veradigm (Allscripts)

Practice Fusion

Chetu

Ensora (formerly NewCrop)

Qualifacts

H2H Solutions

Oracle Health

Optum

DAW (ScriptSure)

Tebra

EverHealth (DrChrono)

Surescripts

RXNT

iPrescribe

E-Prescribing (eRx) Platform Segment by Type

Cloud-based

On-premise

E-Prescribing (eRx) Platform Segment by Application

Physician Practice eRx

Health System eRx

Dental and Behavioral Health eRx

Telehealth eRx

Long-term Care eRx

E-Prescribing (eRx) Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global E-Prescribing (eRx) Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the E-Prescribing (eRx) Platform key companies, revenue, market share, and recent developments.

3. To split the E-Prescribing (eRx) Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions E-Prescribing (eRx) Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify E-Prescribing (eRx) Platform significant trends, drivers, influence factors in global and regions.

6. To analyze E-Prescribing (eRx) Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E-Prescribing (eRx) Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E-Prescribing (eRx) Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E-Prescribing (eRx) Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global E-Prescribing (eRx) Platform industry.

Chapter 3: Detailed analysis of E-Prescribing (eRx) Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of E-Prescribing (eRx) Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of E-Prescribing (eRx) Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. E-Prescribing (eRx) Platform Industry Trends Table 2. E-Prescribing (eRx) Platform Industry Drivers Table 3. E-Prescribing (eRx) Platform Industry Opportunities and Challenges Table 4. E-Prescribing (eRx) Platform Industry Restraints Table 5. Global E-Prescribing (eRx) Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global E-Prescribing (eRx) Platform Revenue Share by Company (2021-2026) Table 7. Global E-Prescribing (eRx) Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global E-Prescribing (eRx) Platform Key Company Manufacturing Base & Headquarters Table 9. Global E-Prescribing (eRx) Platform Company, Product Type & Application Table 10. Global E-Prescribing (eRx) Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global E-Prescribing (eRx) Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premise Table 16. Global E-Prescribing (eRx) Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global E-Prescribing (eRx) Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global E-Prescribing (eRx) Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global E-Prescribing (eRx) Platform Sales Value Share by Type (2021-2026) Table 20. Global E-Prescribing (eRx) Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Physician Practice eRx Table 22. Significant Companies of Health System eRx Table 23. Significant Companies of Dental and Behavioral Health eRx Table 24. Significant Companies of Telehealth eRx Table 25. Significant Companies of Long-term Care eRx Table 26. Global E-Prescribing (eRx) Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global E-Prescribing (eRx) Platform Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global E-Prescribing (eRx) Platform Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global E-Prescribing (eRx) Platform Sales Value Share by Application (2021-2026) Table 30. Global E-Prescribing (eRx) Platform Sales Value Share by Application (2027-2032) Table 31. Global E-Prescribing (eRx) Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global E-Prescribing (eRx) Platform Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global E-Prescribing (eRx) Platform Sales Value Share by Region (2021-2026) Table 34. Global E-Prescribing (eRx) Platform Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global E-Prescribing (eRx) Platform Sales Value Share by Region (2027-2032) Table 36. Global E-Prescribing (eRx) Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global E-Prescribing (eRx) Platform Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global E-Prescribing (eRx) Platform Sales Value Market Share by Country (2021-2026) Table 39. Global E-Prescribing (eRx) Platform Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global E-Prescribing (eRx) Platform Sales Value Market Share by Country (2027-2032) Table 41. MediRecords Company Information Table 42. MediRecords Business Overview Table 43. MediRecords E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. MediRecords E-Prescribing (eRx) Platform Product Portfolio Table 45. MediRecords Recent Development Table 46. RxSure Company Information Table 47. RxSure Business Overview Table 48. RxSure E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. RxSure E-Prescribing (eRx) Platform Product Portfolio Table 50. RxSure Recent Development Table 51. DrFirst Company Information Table 52. DrFirst Business Overview Table 53. DrFirst E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. DrFirst E-Prescribing (eRx) Platform Product Portfolio Table 55. DrFirst Recent Development Table 56. DoseSpot Company Information Table 57. DoseSpot Business Overview Table 58. DoseSpot E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. DoseSpot E-Prescribing (eRx) Platform Product Portfolio Table 60. DoseSpot Recent Development Table 61. Veradigm (Allscripts) Company Information Table 62. Veradigm (Allscripts) Business Overview Table 63. Veradigm (Allscripts) E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Veradigm (Allscripts) E-Prescribing (eRx) Platform Product Portfolio Table 65. Veradigm (Allscripts) Recent Development Table 66. Practice Fusion Company Information Table 67. Practice Fusion Business Overview Table 68. Practice Fusion E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Practice Fusion E-Prescribing (eRx) Platform Product Portfolio Table 70. Practice Fusion Recent Development Table 71. Chetu Company Information Table 72. Chetu Business Overview Table 73. Chetu E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Chetu E-Prescribing (eRx) Platform Product Portfolio Table 75. Chetu Recent Development Table 76. Ensora (formerly NewCrop) Company Information Table 77. Ensora (formerly NewCrop) Business Overview Table 78. Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Product Portfolio Table 80. Ensora (formerly NewCrop) Recent Development Table 81. Qualifacts Company Information Table 82. Qualifacts Business Overview Table 83. Qualifacts E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Qualifacts E-Prescribing (eRx) Platform Product Portfolio Table 85. Qualifacts Recent Development Table 86. H2H Solutions Company Information Table 87. H2H Solutions Business Overview Table 88. H2H Solutions E-Prescribing (eRx) Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. H2H Solutions E-Prescribing (eRx) Platform Product Portfolio Table 90. H2H Solutions Recent Development Table 91. Oracle Health Company Information Table 92. Oracle Health Business Overview Table 93. Oracle Health E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Oracle Health E-Prescribing (eRx) Platform Product Portfolio Table 95. Oracle Health Recent Development Table 96. Optum Company Information Table 97. Optum Business Overview Table 98. Optum E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Optum E-Prescribing (eRx) Platform Product Portfolio Table 100. Optum Recent Development Table 101. DAW (ScriptSure) Company Information Table 102. DAW (ScriptSure) Business Overview Table 103. DAW (ScriptSure) E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. DAW (ScriptSure) E-Prescribing (eRx) Platform Product Portfolio Table 105. DAW (ScriptSure) Recent Development Table 106. Tebra Company Information Table 107. Tebra Business Overview Table 108. Tebra E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Tebra E-Prescribing (eRx) Platform Product Portfolio Table 110. Tebra Recent Development Table 111. EverHealth (DrChrono) Company Information Table 112. EverHealth (DrChrono) Business Overview Table 113. EverHealth (DrChrono) E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. EverHealth (DrChrono) E-Prescribing (eRx) Platform Product Portfolio Table 115. EverHealth (DrChrono) Recent Development Table 116. Surescripts Company Information Table 117. Surescripts Business Overview Table 118. Surescripts E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Surescripts E-Prescribing (eRx) Platform Product Portfolio Table 120. Surescripts Recent Development Table 121. RXNT Company Information Table 122. RXNT Business Overview Table 123. RXNT E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. RXNT E-Prescribing (eRx) Platform Product Portfolio Table 125. RXNT Recent Development Table 126. iPrescribe Company Information Table 127. iPrescribe Business Overview Table 128. iPrescribe E-Prescribing (eRx) Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. iPrescribe E-Prescribing (eRx) Platform Product Portfolio Table 130. iPrescribe Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. E-Prescribing (eRx) Platform Product Image Figure 2. Global E-Prescribing (eRx) Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E-Prescribing (eRx) Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global E-Prescribing (eRx) Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premise Image Figure 9. Global E-Prescribing (eRx) Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global E-Prescribing (eRx) Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global E-Prescribing (eRx) Platform Sales Value Share by Type (2021-2032) Figure 12. Physician Practice eRx Image Figure 13. Health System eRx Image Figure 14. Dental and Behavioral Health eRx Image Figure 15. Telehealth eRx Image Figure 16. Long-term Care eRx Image Figure 17. Global E-Prescribing (eRx) Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global E-Prescribing (eRx) Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global E-Prescribing (eRx) Platform Sales Value Share by Application (2021-2032) Figure 20. Global E-Prescribing (eRx) Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global E-Prescribing (eRx) Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America E-Prescribing (eRx) Platform Sales Value (2021-2032) & (US$ Million) Figure 23. North America E-Prescribing (eRx) Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe E-Prescribing (eRx) Platform Sales Value (2021-2032) & (US$ Million) Figure 25. Europe E-Prescribing (eRx) Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific E-Prescribing (eRx) Platform Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific E-Prescribing (eRx) Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America E-Prescribing (eRx) Platform Sales Value (2021-2032) & (US$ Million) Figure 29. South America E-Prescribing (eRx) Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa E-Prescribing (eRx) Platform Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa E-Prescribing (eRx) Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Physician Practice eRx
  • Health System eRx
  • Dental and Behavioral Health eRx
  • Telehealth eRx
  • Long-term Care eRx
Companies covered
  • MediRecords
  • RxSure
  • DrFirst
  • DoseSpot
  • Veradigm (Allscripts)
  • Practice Fusion
  • Chetu
  • Ensora (formerly NewCrop)
  • Qualifacts
  • H2H Solutions
  • Oracle Health
  • Optum
  • DAW (ScriptSure)
  • Tebra
  • EverHealth (DrChrono)
  • Surescripts
  • RXNT
  • iPrescribe

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global E-Prescribing (eRx) Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global E-Prescribing (eRx) Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 E-Prescribing (eRx) Platform Market Dynamics
  1. 2.1 E-Prescribing (eRx) Platform Industry Trends
  2. 2.2 E-Prescribing (eRx) Platform Industry Drivers
  3. 2.3 E-Prescribing (eRx) Platform Industry Opportunities and Challenges
  4. 2.4 E-Prescribing (eRx) Platform Industry Restraints
3 E-Prescribing (eRx) Platform Market by Company
  1. 3.1 Global E-Prescribing (eRx) Platform Company Revenue Ranking in 2025
  2. 3.2 Global E-Prescribing (eRx) Platform Revenue by Company (2021-2026)
  3. 3.3 Global E-Prescribing (eRx) Platform Company Ranking (2024-2026)
  4. 3.4 Global E-Prescribing (eRx) Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global E-Prescribing (eRx) Platform Company Product Type and Application
  6. 3.6 Global E-Prescribing (eRx) Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global E-Prescribing (eRx) Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 E-Prescribing (eRx) Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 E-Prescribing (eRx) Platform Market by Type
  1. 4.1 E-Prescribing (eRx) Platform Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premise
  4. 4.2 Global E-Prescribing (eRx) Platform Sales Value by Type
  5. 4.2.1 Global E-Prescribing (eRx) Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global E-Prescribing (eRx) Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global E-Prescribing (eRx) Platform Sales Value Share by Type (2021-2032)
5 E-Prescribing (eRx) Platform Market by Application
  1. 5.1 E-Prescribing (eRx) Platform Application Introduction
  2. 5.1.1 Physician Practice eRx
  3. 5.1.2 Health System eRx
  4. 5.1.3 Dental and Behavioral Health eRx
  5. 5.1.4 Telehealth eRx
  6. 5.1.5 Long-term Care eRx
  7. 5.2 Global E-Prescribing (eRx) Platform Sales Value by Application
  8. 5.2.1 Global E-Prescribing (eRx) Platform Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global E-Prescribing (eRx) Platform Sales Value by Application (2021-2032)
  10. 5.2.3 Global E-Prescribing (eRx) Platform Sales Value Share by Application (2021-2032)
6 E-Prescribing (eRx) Platform Regional Value Analysis
  1. 6.1 Global E-Prescribing (eRx) Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global E-Prescribing (eRx) Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global E-Prescribing (eRx) Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global E-Prescribing (eRx) Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America E-Prescribing (eRx) Platform Sales Value (2021-2032)
  7. 6.3.2 North America E-Prescribing (eRx) Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe E-Prescribing (eRx) Platform Sales Value (2021-2032)
  10. 6.4.2 Europe E-Prescribing (eRx) Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific E-Prescribing (eRx) Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific E-Prescribing (eRx) Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America E-Prescribing (eRx) Platform Sales Value (2021-2032)
  16. 6.6.2 South America E-Prescribing (eRx) Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa E-Prescribing (eRx) Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa E-Prescribing (eRx) Platform Sales Value Share by Country, 2025 VS 2032
7 E-Prescribing (eRx) Platform Country-level Value Analysis
  1. 7.1 Global E-Prescribing (eRx) Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global E-Prescribing (eRx) Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global E-Prescribing (eRx) Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global E-Prescribing (eRx) Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt E-Prescribing (eRx) Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt E-Prescribing (eRx) Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt E-Prescribing (eRx) Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 MediRecords
  2. 8.1.1 MediRecords Company Information
  3. 8.1.2 MediRecords Business Overview
  4. 8.1.3 MediRecords E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 MediRecords E-Prescribing (eRx) Platform Product Portfolio
  6. 8.1.5 MediRecords Recent Developments
  7. 8.2 RxSure
  8. 8.2.1 RxSure Company Information
  9. 8.2.2 RxSure Business Overview
  10. 8.2.3 RxSure E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 RxSure E-Prescribing (eRx) Platform Product Portfolio
  12. 8.2.5 RxSure Recent Developments
  13. 8.3 DrFirst
  14. 8.3.1 DrFirst Company Information
  15. 8.3.2 DrFirst Business Overview
  16. 8.3.3 DrFirst E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DrFirst E-Prescribing (eRx) Platform Product Portfolio
  18. 8.3.5 DrFirst Recent Developments
  19. 8.4 DoseSpot
  20. 8.4.1 DoseSpot Company Information
  21. 8.4.2 DoseSpot Business Overview
  22. 8.4.3 DoseSpot E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DoseSpot E-Prescribing (eRx) Platform Product Portfolio
  24. 8.4.5 DoseSpot Recent Developments
  25. 8.5 Veradigm (Allscripts)
  26. 8.5.1 Veradigm (Allscripts) Company Information
  27. 8.5.2 Veradigm (Allscripts) Business Overview
  28. 8.5.3 Veradigm (Allscripts) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Veradigm (Allscripts) E-Prescribing (eRx) Platform Product Portfolio
  30. 8.5.5 Veradigm (Allscripts) Recent Developments
  31. 8.6 Practice Fusion
  32. 8.6.1 Practice Fusion Company Information
  33. 8.6.2 Practice Fusion Business Overview
  34. 8.6.3 Practice Fusion E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Practice Fusion E-Prescribing (eRx) Platform Product Portfolio
  36. 8.6.5 Practice Fusion Recent Developments
  37. 8.7 Chetu
  38. 8.7.1 Chetu Company Information
  39. 8.7.2 Chetu Business Overview
  40. 8.7.3 Chetu E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Chetu E-Prescribing (eRx) Platform Product Portfolio
  42. 8.7.5 Chetu Recent Developments
  43. 8.8 Ensora (formerly NewCrop)
  44. 8.8.1 Ensora (formerly NewCrop) Company Information
  45. 8.8.2 Ensora (formerly NewCrop) Business Overview
  46. 8.8.3 Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ensora (formerly NewCrop) E-Prescribing (eRx) Platform Product Portfolio
  48. 8.8.5 Ensora (formerly NewCrop) Recent Developments
  49. 8.9 Qualifacts
  50. 8.9.1 Qualifacts Company Information
  51. 8.9.2 Qualifacts Business Overview
  52. 8.9.3 Qualifacts E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qualifacts E-Prescribing (eRx) Platform Product Portfolio
  54. 8.9.5 Qualifacts Recent Developments
  55. 8.10 H2H Solutions
  56. 8.10.1 H2H Solutions Company Information
  57. 8.10.2 H2H Solutions Business Overview
  58. 8.10.3 H2H Solutions E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 H2H Solutions E-Prescribing (eRx) Platform Product Portfolio
  60. 8.10.5 H2H Solutions Recent Developments
  61. 8.11 Oracle Health
  62. 8.11.1 Oracle Health Company Information
  63. 8.11.2 Oracle Health Business Overview
  64. 8.11.3 Oracle Health E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Oracle Health E-Prescribing (eRx) Platform Product Portfolio
  66. 8.11.5 Oracle Health Recent Developments
  67. 8.12 Optum
  68. 8.12.1 Optum Company Information
  69. 8.12.2 Optum Business Overview
  70. 8.12.3 Optum E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Optum E-Prescribing (eRx) Platform Product Portfolio
  72. 8.12.5 Optum Recent Developments
  73. 8.13 DAW (ScriptSure)
  74. 8.13.1 DAW (ScriptSure) Company Information
  75. 8.13.2 DAW (ScriptSure) Business Overview
  76. 8.13.3 DAW (ScriptSure) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DAW (ScriptSure) E-Prescribing (eRx) Platform Product Portfolio
  78. 8.13.5 DAW (ScriptSure) Recent Developments
  79. 8.14 Tebra
  80. 8.14.1 Tebra Company Information
  81. 8.14.2 Tebra Business Overview
  82. 8.14.3 Tebra E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Tebra E-Prescribing (eRx) Platform Product Portfolio
  84. 8.14.5 Tebra Recent Developments
  85. 8.15 EverHealth (DrChrono)
  86. 8.15.1 EverHealth (DrChrono) Company Information
  87. 8.15.2 EverHealth (DrChrono) Business Overview
  88. 8.15.3 EverHealth (DrChrono) E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 EverHealth (DrChrono) E-Prescribing (eRx) Platform Product Portfolio
  90. 8.15.5 EverHealth (DrChrono) Recent Developments
  91. 8.16 Surescripts
  92. 8.16.1 Surescripts Company Information
  93. 8.16.2 Surescripts Business Overview
  94. 8.16.3 Surescripts E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Surescripts E-Prescribing (eRx) Platform Product Portfolio
  96. 8.16.5 Surescripts Recent Developments
  97. 8.17 RXNT
  98. 8.17.1 RXNT Company Information
  99. 8.17.2 RXNT Business Overview
  100. 8.17.3 RXNT E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 RXNT E-Prescribing (eRx) Platform Product Portfolio
  102. 8.17.5 RXNT Recent Developments
  103. 8.18 iPrescribe
  104. 8.18.1 iPrescribe Company Information
  105. 8.18.2 iPrescribe Business Overview
  106. 8.18.3 iPrescribe E-Prescribing (eRx) Platform Revenue and Gross Margin (2021-2026)
  107. 8.18.4 iPrescribe E-Prescribing (eRx) Platform Product Portfolio
  108. 8.18.5 iPrescribe Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst